HLVX
Income statement / Annual
Last year (2023), HilleVax, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, HilleVax, Inc.'s net income was -$123.57 M.
See HilleVax, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$2.16 M |
$2.25 M |
$3,000.00 |
$0.00 |
$0.00 |
| Gross Profit |
-$2.16 M |
-$2.25 M |
-$3,000.00 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$106.68 M
|
$45.91 M
|
$10.01 M
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$26.66 M
|
$16.71 M
|
$5.76 M
|
$1.30 M
|
$633,000.00
|
| Selling & Marketing
Expenses |
-$2.16 M
|
$0.00
|
$0.00
|
$0.00
|
$632,367.00
|
| Selling, General &
Administrative Expenses |
$26.66 M
|
$16.71 M
|
$5.76 M
|
$1.30 M
|
$633,000.00
|
| Other Expenses |
$0.00 |
-$94.70 M |
-$20.23 M |
-$779,000.00 |
$0.00 |
| Operating Expenses |
$133.35 M |
$62.61 M |
$15.77 M |
$1.30 M |
$633,000.00 |
| Cost And Expenses |
$133.35 M |
$62.61 M |
$15.77 M |
$1.30 M |
$633,000.00 |
| Interest Income |
$9.71 M |
$3.88 M |
$2,844.00 |
$29.00 |
$9.00 |
| Interest Expense |
$2.39 M |
$3.41 M |
$2.84 M |
$29,000.00 |
$9,000.00 |
| Depreciation &
Amortization |
$879,000.00
|
$2.25 M
|
$3,000.00
|
$1.30 M
|
$633,000.00
|
| EBITDA |
-$132.47 M
|
-$60.11 M
|
-$35.99 M
|
-$2.07 M
|
-$633,000.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$9.78 M
|
-$94.70 M
|
-$48.98 M
|
-$808,000.00
|
-$40,000.00
|
| Income Before Tax |
-$123.57 M |
-$159.81 M |
-$102.41 M |
-$2.10 M |
-$673,000.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$97.20 M |
-$17.38 M |
$29,000.00 |
-$633.00 |
| Net Income |
-$123.57 M |
-$257.01 M |
-$85.03 M |
-$2.13 M |
-$673,000.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-3.04 |
-6.83 |
-2.82 |
-0.0706 |
-0.0223 |
| EPS Diluted |
-3.04 |
-6.83 |
-2.82 |
-0.0706 |
-0.0223 |
| Weighted Average Shares
Out |
$40.60 M
|
$37.66 M
|
$30.19 M
|
$30.19 M
|
$30.19 M
|
| Weighted Average Shares
Out Diluted |
$40.60 M
|
$37.66 M
|
$30.19 M
|
$30.19 M
|
$30.19 M
|
| Link |
|
|
|
|
|
